Abbott's MDx Sales Rise 16 Percent in Q3

The firm also expects to launch at least a dozen new molecular diagnostics products over the next two to three years.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories